| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.005 | 30.438 | 31.504 | 33.690 | 35.071 | 33.375 | 39.449 | 33.822 | 33.108 | 29.827 |
| Total Income - EUR | 26.005 | 30.444 | 31.571 | 33.690 | 35.082 | 33.549 | 39.449 | 33.822 | 33.108 | 29.827 |
| Total Expenses - EUR | 20.523 | 24.459 | 13.308 | 24.807 | 24.191 | 20.459 | 23.231 | 22.486 | 25.120 | 25.438 |
| Gross Profit/Loss - EUR | 5.482 | 5.985 | 18.262 | 8.883 | 10.891 | 13.090 | 16.218 | 11.335 | 7.988 | 4.389 |
| Net Profit/Loss - EUR | 4.702 | 5.681 | 17.947 | 8.546 | 10.540 | 12.758 | 15.823 | 10.997 | 7.657 | 3.634 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Regynobstetrics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 562 | 559 | 549 | 548 | 537 | 527 | 515 | 517 | 516 | 513 |
| Current Assets | 19.851 | 10.939 | 18.906 | 25.000 | 35.361 | 41.250 | 52.100 | 55.726 | 42.144 | 46.095 |
| Inventories | 9.190 | 0 | 577 | 0 | 250 | 245 | 0 | 0 | 0 | 0 |
| Receivables | 8.317 | 9.052 | 9.314 | 9.526 | 11.731 | 10.993 | 9.381 | 9.725 | 9.791 | 9.769 |
| Cash | 2.344 | 1.887 | 9.014 | 15.475 | 23.380 | 30.012 | 42.719 | 46.001 | 32.353 | 36.326 |
| Shareholders Funds | -5.255 | 479 | 18.419 | 24.477 | 34.543 | 40.444 | 51.328 | 54.847 | 54.757 | 58.085 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.668 | 11.018 | 1.036 | 1.071 | 1.356 | 1.333 | 1.288 | 1.396 | 2.054 | 2.595 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Regynobstetrics Srl